Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061013314> ?p ?o ?g. }
- W2061013314 endingPage "C44" @default.
- W2061013314 startingPage "C38" @default.
- W2061013314 abstract "The number of vaccines available and included as part of the national immunization schedules, has increased significantly over the past few decades. This impacts on patient/parent compliance and creates a challenge for health care providers for implementation of schedules necessitating training and infrastructure improvements. Use of combination rather than component vaccines offers advantages for compliance by single dose administration of various antigens, reducing stock costing as well as reducing cost of additional health care visits. Combination vaccines are often significantly more expensive than individual constituent vaccines. Concerns regarding an increased incidence of adverse events with use of combination vaccines have not been confirmed and rates may seem high as the adverse events seem to mimic the sum total of adverse event rates for each individual antigen used but may in fact be lower. Manufacturers typically advise against interchanging use of vaccine products. Despite this, health authorities advocate use of an alternative vaccine where the original vaccine in not available, to ensure continuity of vaccination. A notable exception is the acellular pertussis vaccine. Partly, because no serological correlates of immunity exist, but also a general lack of convincing follow up studies has prompted the recommendation for manufacturer fidelity for at least the first 3 vaccine doses. According to the South African Medicines Formulary, a variety of vaccines are available in South Africa. Although a large number are available in the private sector, the only true combination vaccine included in the current state EPI, modified in 2009, is the DTaP-IPV/Hib vaccine (Diphtheria, Tetanus, acellular Pertussis, inactivated Poliomyelitis virus and Haemophilus influenzae type b). There are many reasons justifying the use of combination vaccines rather that the individual constituent formulations. Implementation of use in the South African setting at this point is still limited, but may offer an exciting avenue of expanding the antigen repertoire without impacting on side-effects, efficacy or complexity of scheduling." @default.
- W2061013314 created "2016-06-24" @default.
- W2061013314 creator A5008106116 @default.
- W2061013314 creator A5074219839 @default.
- W2061013314 date "2012-09-01" @default.
- W2061013314 modified "2023-09-25" @default.
- W2061013314 title "Combination vaccines in the South African setting" @default.
- W2061013314 cites W1590173188 @default.
- W2061013314 cites W1966597526 @default.
- W2061013314 cites W1969411429 @default.
- W2061013314 cites W1969590818 @default.
- W2061013314 cites W1973359960 @default.
- W2061013314 cites W1978700772 @default.
- W2061013314 cites W1979841030 @default.
- W2061013314 cites W1985449251 @default.
- W2061013314 cites W1986138546 @default.
- W2061013314 cites W1994036990 @default.
- W2061013314 cites W1996682693 @default.
- W2061013314 cites W2001698553 @default.
- W2061013314 cites W2003760521 @default.
- W2061013314 cites W2010065791 @default.
- W2061013314 cites W2015401955 @default.
- W2061013314 cites W2016719551 @default.
- W2061013314 cites W2030054740 @default.
- W2061013314 cites W2040740588 @default.
- W2061013314 cites W2046116284 @default.
- W2061013314 cites W2046587099 @default.
- W2061013314 cites W2047737222 @default.
- W2061013314 cites W2050509289 @default.
- W2061013314 cites W2050542860 @default.
- W2061013314 cites W2053610542 @default.
- W2061013314 cites W2060450549 @default.
- W2061013314 cites W2060866015 @default.
- W2061013314 cites W2063104389 @default.
- W2061013314 cites W2063947655 @default.
- W2061013314 cites W2066304648 @default.
- W2061013314 cites W2071519811 @default.
- W2061013314 cites W2071619097 @default.
- W2061013314 cites W2073475883 @default.
- W2061013314 cites W2077312374 @default.
- W2061013314 cites W2087702855 @default.
- W2061013314 cites W2089856958 @default.
- W2061013314 cites W2092145494 @default.
- W2061013314 cites W2092963057 @default.
- W2061013314 cites W2098744535 @default.
- W2061013314 cites W2101555255 @default.
- W2061013314 cites W2106952837 @default.
- W2061013314 cites W2120597337 @default.
- W2061013314 cites W2138526581 @default.
- W2061013314 cites W2138530540 @default.
- W2061013314 cites W2140484542 @default.
- W2061013314 cites W2142474210 @default.
- W2061013314 cites W2163284997 @default.
- W2061013314 cites W2164862137 @default.
- W2061013314 cites W2283104788 @default.
- W2061013314 cites W2318319114 @default.
- W2061013314 cites W2321059348 @default.
- W2061013314 cites W2324967517 @default.
- W2061013314 cites W2414529599 @default.
- W2061013314 doi "https://doi.org/10.1016/j.vaccine.2012.05.001" @default.
- W2061013314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22939020" @default.
- W2061013314 hasPublicationYear "2012" @default.
- W2061013314 type Work @default.
- W2061013314 sameAs 2061013314 @default.
- W2061013314 citedByCount "3" @default.
- W2061013314 countsByYear W20610133142012 @default.
- W2061013314 countsByYear W20610133142022 @default.
- W2061013314 crossrefType "journal-article" @default.
- W2061013314 hasAuthorship W2061013314A5008106116 @default.
- W2061013314 hasAuthorship W2061013314A5074219839 @default.
- W2061013314 hasBestOaLocation W20610133142 @default.
- W2061013314 hasConcept C100406419 @default.
- W2061013314 hasConcept C126322002 @default.
- W2061013314 hasConcept C147483822 @default.
- W2061013314 hasConcept C160735492 @default.
- W2061013314 hasConcept C162324750 @default.
- W2061013314 hasConcept C177713679 @default.
- W2061013314 hasConcept C197934379 @default.
- W2061013314 hasConcept C203014093 @default.
- W2061013314 hasConcept C22070199 @default.
- W2061013314 hasConcept C2780572238 @default.
- W2061013314 hasConcept C2780801004 @default.
- W2061013314 hasConcept C50522688 @default.
- W2061013314 hasConcept C512399662 @default.
- W2061013314 hasConcept C71924100 @default.
- W2061013314 hasConceptScore W2061013314C100406419 @default.
- W2061013314 hasConceptScore W2061013314C126322002 @default.
- W2061013314 hasConceptScore W2061013314C147483822 @default.
- W2061013314 hasConceptScore W2061013314C160735492 @default.
- W2061013314 hasConceptScore W2061013314C162324750 @default.
- W2061013314 hasConceptScore W2061013314C177713679 @default.
- W2061013314 hasConceptScore W2061013314C197934379 @default.
- W2061013314 hasConceptScore W2061013314C203014093 @default.
- W2061013314 hasConceptScore W2061013314C22070199 @default.
- W2061013314 hasConceptScore W2061013314C2780572238 @default.
- W2061013314 hasConceptScore W2061013314C2780801004 @default.
- W2061013314 hasConceptScore W2061013314C50522688 @default.
- W2061013314 hasConceptScore W2061013314C512399662 @default.